Disciplined Investments, LLC Gilead Sciences, Inc. Transaction History

Disciplined Investments, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	SELL	$76.01 - $86.7 $152 - $173	-2 Reduced 2.04%	96 $7,000
Q1 2023 May 10, 2023	SELL	$77.31 - $88.08 $695 - $792	-9 Reduced 8.41%	98 $8,000
Q4 2022 Feb 01, 2023	BUY	$62.32 - $89.47 $249 - $357	4 Added 3.88%	107 $9,000
Q3 2022 Nov 03, 2022	BUY	$59.54 - $68.01 $893 - $1,020	15 Added 17.05%	103 $6,000
Q2 2022 Aug 09, 2022	BUY	$57.72 - $65.01 $404 - $455	7 Added 8.64%	88 $5,000
Q1 2022 Apr 22, 2022	BUY	$57.92 - $72.58 $1,969 - $2,467	34 Added 72.34%	81 $5,000
Q1 2021 May 12, 2021	BUY	$60.0 - $68.46 $840 - $958	14 Added 42.42%	47 $3,000
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $16,428 - $18,719	-290 Reduced 89.78%	33 $2,000
Q3 2020 Nov 05, 2020	BUY	$62.1 - $78.08 $6,210 - $7,808	100 Added 44.84%	323 $20,000
Q4 2019 May 19, 2020	BUY	$61.62 - $67.78 $13,741 - $15,114	223 New	223 $14,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Disciplined Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Disciplined Investments, LLC with notifications on news.